PDIA4 targets IRE1α/sXBP1 to alleviate NLRP3 inflammasome activation and renal tubular injury in diabetic kidney disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025-03 · 1871 (3) · 167645
DOI: 10.1016/j.bbadis.2024.167645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025-03. Verfasst von Xuan Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Diabetic Nephropathies, Protein Serine-Threonine Kinases, Inflammasomes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Nankai University, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
The role of ER stress in the pathogenesis of diabetic kidney diseases (DKD) remains unclear. We employed bioinformatics to identify the UPR pathway activation, inflammation, and programmed cell death patterns in diabetic tubules. Levels of IRE1α/sXBP1 signaling, NLRP3 inflammasome activity and pyroptosis in tubular cells under high glucose conditions were measured. IRE1α knockdown was used to determine its role in glucose-triggered activation of the NLRP3 inflammasome and pyroptosis. PDIA4 overexpression and silencing were used to assess its impact on the IRE1α/sXBP1 pathway. The dynamic interaction among PDIA4, GRP78, and IRE1α under high glucose were analyzed using immunoprecipitation and crosslinking assays. In STZ-induced and db/db mouse models of DKD, the regulatory role of PDIA4 on IRE1α/sXBP1 signaling and diabetic tubular inflammation and injury were evaluated. Our study showed that IRE1α/sXBP1, NLRP3 inflammasome, and pyroptosis are activated in the renal tubules of DKD patients. Induction of IRE1α pathway mediated the glucose-triggered activation of the NLRP3 inflammasome and pyroptosis. Moreover, overexpression of PDIA4 decreased the activation of IRE1α/sXBP1 under high glucose conditions. High glucose leads to the release of GRP78 from IRE1α and an increased interaction between IRE1α and PDIA4. In mouse models of DKD, overexpressing PDIA4 mitigated diabetic tubular injury and inflammation, marked by decreased IRE1α/sXBP1 and NLRP3 inflammasome. In conclusion, our findings demonstrate that high glucose triggers NLRP3 inflammasome and pyroptosis via the IRE1α/sXBP1 pathway in renal tubular cells. Overexpression of PDIA4 suppresses IRE1α signaling by binding to its oligomeric form, implying a promising therapeutic intervention for DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, Nankai University, Tianjin, China.
- Dongfang Hospital of Beijing University of Chinese medicine, Beijing, China.
- Department of Pathology, School of Medicine, Nankai University, Tianjin, China. Electronic address: wangdekun@nankai.edu.cn.
- Department of Pathology, School of Medicine, Nankai University, Tianjin, China. Electronic address: xiaoyuetan@nankai.edu.cn.
Förderung
- Nankai University
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Zhou, D., Su, Y., Liu, H., Su, Q., Shen, T., Zhang, M., Mi, X., Zhang, Y., Yue, S., Zhang, Z., Wang, D., & Tan, X. (2025). PDIA4 targets IRE1α/sXBP1 to alleviate NLRP3 inflammasome activation and renal tubular injury in diabetic kidney disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1871(3), 167645. https://doi.org/10.1016/j.bbadis.2024.167645
Vancouver
Liu X, Zhou D, Su Y, Liu H, Su Q, Shen T, et al. PDIA4 targets IRE1α/sXBP1 to alleviate NLRP3 inflammasome activation and renal tubular injury in diabetic kidney disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025;1871(3):167645. doi:10.1016/j.bbadis.2024.167645
BibTeX
@article{Liu2025,
author = {Liu, Xuan and Zhou, Donghui and Su, Yu and Liu, Hongling and Su, Qiuyue and Shen, Tianyu and Zhang, Mianzhi and Mi, Xue and Zhang, Yuying and Yue, Shijing and Zhang, Zhujun and Wang, Dekun and Tan, Xiaoyue},
title = {PDIA4 targets IRE1α/sXBP1 to alleviate NLRP3 inflammasome activation and renal tubular injury in diabetic kidney disease},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2025},
volume = {1871},
number = {3},
pages = {167645},
doi = {10.1016/j.bbadis.2024.167645}
}
EUVIMED